https://www.avient.com/news/mecall-srl-replaces-lead-trilliant-radiation-shielding-polyone
PolyOne Trilliant injection moldable solutions block radiation as effectively as lead, providing medical device manufacturers with an easy-to-manufacture and more sustainable alternative,” said Holger Kronimus, vice president, Europe and general manager, Engineered Materials Europe, PolyOne Corporation.
SEARCH INVESTOR NEWS
https://www.avient.com/news/new-european-fire-safety-standards-met-polyone’s-eccoh-formulations-wire-and-cable
Together with the proper cable design, our ECCOH specialty formulations will help manufacturers meet CPR requirements for all power, control and communication cables used in buildings, including optical fiber cables,” said Holger Kronimus, VP Europe and general manager, Specialty Engineered Materials, PolyOne.
SEARCH INVESTOR NEWS
https://www.avient.com/news/polyone-invests-new-metal-replacement-capabilities
PolyOne has a proven track record of innovating and collaborating with our customers to develop specialty formulations that meet their specific performance needs,” said Craig Nikrant, president, Global Specialty Engineered Materials, PolyOne Corporation.
SEARCH INVESTOR NEWS
https://www.avient.com/news/polyone-showcases-solutions-efficient-manufacturing-wire-2014
Holger Kronimus, PolyOne vice president Europe and general manager, Specialty Engineered Materials Europe, commented, “We’ve recently developed several technologies in close collaboration with customers that help to improve manufacturing efficiency while also addressing the need for sustainable operations and products.”
SEARCH INVESTOR NEWS
https://www.avient.com/news/polyone-showcases-automotive-interior-surface-solutions-wardsauto-interiors-conference
– PolyOne Corporation (NYSE: POL), a premier global provider of specialized polymer materials, services and solutions, presents its specialty portfolio for automotive interiors to designers and engineers today at the 2014 WardsAuto Interiors conference.
SEARCH INVESTOR NEWS
https://www.avient.com/products/thermoplastic-elastomers/versaflex-hc-thermoplastic-elastomers
Specialty Engineered Materials for Healthcare
Specialty Engineered Materials for Healthcare (Chinese)
TPEs and Specialty Engineered Materials for Auto-injector Pens
https://www.avient.com/sites/default/files/2022-10/Cesa WithStand Patient Mobility Case Study %281%29.pdf
ANTIMICROBIAL PROTECTION AND VIBRANT COLOR, ALL IN ONE STEP Challe nge Accepted.
THE IMPACT • FLEXIBILITY through wide range of color options • PROTECTION of product through antimicrobial technology • SPEED to MARKET through supplier expertise • COST REDUCTION through simplified processing • CONSISTENT performance through all-inclusive, one step masterbatch Each Smartbatch solution is custom formulated to incorporate color, antimicrobial technology and UV stability in one material, simplifying them manufacturing process and delivering consistent performance. © 2022, All Rights Reserved Avient Corporation, 33587 Walker Road, Avon Lake, Ohio USA 44012 ANTIMICROBIAL TECHNOLOGY, CUSTOM COLORS AND PERFORMANCE ADDITIVES IN ONE MASTERBATCH.
https://www.avient.com/sites/default/files/2023-02/AVNT Q4 2022 Earnings Press Release-1.pdf
A recording of the webcast and the slide presentation will be available at avient.com/investors/events-presentations immediately following the conference call and will be accessible for one year. https://www.avient.com/investors https://edge.media-server.com/mmc/p/a8tcrg4m https://www.avient.com/investors https://register.vevent.com/register/BI125445d5780d4c898d63ec3c1fa53045 https://www.avient.com/investors/events-presentations 5 About Avient Avient Corporation (NYSE: AVNT) provides specialized and sustainable material solutions that transform customer challenges into opportunities, bringing new products to life for a better world.
Three Months Ended December 31, 2022 2021 Reconciliation to Condensed Consolidated Statements of Income $ EPS(1) $ EPS(1) Net (loss) income from continuing operations attributable to Avient shareholders $ (17.0) $ (0.19) $ 11.2 $ 0.12 Special items, after tax (Attachment 3) 38.3 0.42 23.9 0.26 Amortization expense, after-tax 14.6 0.16 11.3 0.12 Adjusted net income / EPS $ 35.9 $ 0.39 $ 46.4 $ 0.50 (1) Per share amounts may not recalculate from figures presented herein due to rounding Year Ended December 31, 2022 2021 Reconciliation to Condensed Consolidated Statements of Income $ EPS(1) $ EPS(1) Net income from continuing operations attributable to Avient shareholders $ 82.8 $ 0.90 $ 151.8 $ 1.65 Special items, after tax (Attachment 3) 116.2 1.26 50.0 0.54 Amortization expense, after-tax 49.0 0.53 44.9 0.49 Adjusted net income / EPS $ 248.0 $ 2.69 $ 246.7 $ 2.68 (1) Per share amounts may not recalculate from figures presented herein due to rounding 9 Attachment 2 Avient Corporation Condensed Consolidated Statements of Income (Unaudited) (In millions, except per share data) Three Months Ended December 31, Year Ended December 31, 2022 2021 2022 2021 Sales $ 790.4 $ 807.1 $ 3,396.9 $ 3,315.5 Cost of sales 618.4 590.5 2,514.2 2,371.7 Gross margin 172.0 216.6 882.7 943.8 Selling and administrative expense 171.6 166.4 639.4 664.1 Operating income 0.4 50.2 243.3 279.7 Interest expense, net (49.4) (17.5) (119.8) (75.2) Other expense, net (28.4) (5.3) (59.7) (1.0) (Loss) income from continuing operations before income taxes (77.4) 27.4 63.8 203.5 Income tax benefit (expense) 60.8 (17.1) 19.3 (51.9) Net (loss) income from continuing operations (16.6) 10.3 83.1 151.6 Income from discontinued operations, net of income taxes 561.5 18.7 620.3 79.0 Net income 544.9 29.0 703.4 230.6 Net (income) loss attributable to noncontrolling interests (0.4) 0.9 (0.3) 0.2 Net income attributable to Avient common shareholders $ 544.5 $ 29.9 $ 703.1 $ 230.8 Earnings per share attributable to Avient common shareholders - Basic: Continuing operations $ (0.19) $ 0.12 $ 0.91 $ 1.66 Discontinued operations 6.17 0.21 6.80 0.87 Total $ 5.98 $ 0.33 $ 7.71 $ 2.53 Earnings per share attributable to Avient common shareholders - Diluted: Continuing operations $ (0.19) $ 0.12 $ 0.90 $ 1.65 Discontinued operations 6.17 0.20 6.73 0.86 Total $ 5.98 $ 0.32 $ 7.63 $ 2.51 Cash dividends declared per share of common stock $ 0.2475 $ 0.2375 $ 0.9600 $ 0.8750 Weighted-average shares used to compute earnings per common share: Basic 91.0 91.5 91.2 91.4 Diluted 91.0 92.4 92.2 92.1 10 Attachment 3 Avient Corporation Summary of Special Items (Unaudited) (In millions, except per share data) Special items (1) Three Months Ended December 31, Year Ended December 31, 2022 2021 2022 2021 Cost of sales: Restructuring costs, including accelerated depreciation $ (21.3) $ (6.0) $ (31.1) $ (14.6) Environmental remediation costs (0.4) (0.5) (24.2) (22.9) Reimbursement of previously incurred environmental costs — — 8.3 4.5 Acquisition related costs (23.8) 0.6 (34.1) (0.6) Impact on cost of sales (45.5) (5.9) (81.1) (33.6) Selling and administrative expense: Restructuring, legal and other (8.3) (4.2) (8.3) (5.9) Acquisition related costs (6.1) (1.1) (19.3) (8.3) Impact on selling and administrative expense (14.4) (5.3) (27.6) (14.2) Impact on operating income (59.9) (11.2) (108.7) (47.8) Interest expense, net - committed financing and debt extinguishment (16.0) — (26.0) — Mark-to-market on derivatives — — (30.9) — Pension and post retirement mark-to-market adjustment and other (28.4) (9.3) (28.4) (9.3) Impact on Other expense, net (28.4) (9.3) (59.3) (9.3) Impact on income from continuing operations before income taxes (104.3) (20.5) (194.0) (57.1) Income tax benefit benefit/(expense) on above special items 26.8 4.1 49.4 13.0 Tax adjustments(2) 39.2 (7.5) 28.4 (5.9) Impact of special items on net income from continuing operations $ (38.3) $ (23.9) $ (116.2) $ (50.0) Diluted earnings per common share impact $ (0.42) $ (0.26) $ (1.26) $ (0.54) Weighted average shares used to compute adjusted earnings per share: Diluted 91.7 92.4 92.2 92.1 (1) Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; costs incurred directly in relation to acquisitions or divestitures; employee separation costs resulting from personnel reduction programs, plant realignment costs, executive separation agreements; asset impairments; settlement gains or losses and mark-to- market adjustments associated with actuarial gains and losses on pension and other post-retirement benefit plans; environmental remediation costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, joint ventures and equity investments; gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non-recurring items; and the effect of changes in accounting principles or other such laws or provisions affecting reported results. (2) Tax adjustments include the net tax benefit/(expense) from non-recurring income tax items, adjustments to uncertain tax position reserves and deferred income tax valuation allowances. 11 Attachment 4 Avient Corporation Condensed Consolidated Balance Sheets (Unaudited) (In millions) Year Ended December 31, 2022 2021 ASSETS Current assets: Cash and cash equivalents $ 641.1 $ 601.2 Accounts receivable, net 440.6 439.9 Inventories, net 372.7 305.8 Current assets held for sale — 360.2 Other current assets 115.3 119.9 Total current assets 1,569.7 1,827.0 Property, net 1,049.2 672.3 Goodwill 1,671.9 1,284.8 Intangible assets, net 1,597.6 925.2 Operating lease assets, net 60.4 58.2 Non-current assets held for sale — 22.0 Other non-current assets 136.2 207.7 Total assets $ 6,085.0 $ 4,997.2 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Short-term and current portion of long-term debt $ 2.2 $ 8.6 Accounts payable 454.4 429.5 Current operating lease obligations 17.0 21.1 Current liabilities held for sale — 141.3 Accrued expenses and other current liabilities 395.8 340.2 Total current liabilities 869.4 940.7 Non-current liabilities: Long-term debt 2,176.7 1,850.3 Pension and other post-retirement benefits 67.2 99.9 Deferred income taxes 342.5 100.6 Non-current operating lease obligations 40.9 37.3 Non-current liabilities held for sale — 13.1 Other non-current liabilities 235.5 164.8 Total non-current liabilities 2,862.8 2,266.0 SHAREHOLDERS' EQUITY Avient shareholders’ equity 2,334.5 1,774.7 Noncontrolling interest 18.3 15.8 Total equity 2,352.8 1,790.5 Total liabilities and equity $ 6,085.0 $ 4,997.2 12 Attachment 5 Avient Corporation Condensed Consolidated Statements of Cash Flows (Unaudited) (In millions) Year Ended December 31, 2022 2021 Operating activities Net income $ 703.4 $ 230.6 Adjustments to reconcile net income to net cash provided by operating activities: Gain on sale of business, net of tax expense (550.1) — Depreciation and amortization 157.6 144.2 Accelerated depreciation 5.5 1.7 Amortization of inventory step-up 34.4 1.5 Deferred income tax expense (benefit) 0.5 (27.3) Share-based compensation expense 13.2 11.2 Changes in assets and liabilities, net of the effect of acquisitions: Decrease (increase) in accounts receivable 32.6 (143.1) Decrease (increase) in inventories 14.0 (141.0) Increase in accounts payable 10.7 95.3 Increase (decrease) in pension and other post-retirement benefits 7.1 (10.9) Taxes paid on gain on divestiture (2.8) — (Decrease) increase in accrued expenses and other assets and liabilities, net (27.7) 71.6 Net cash provided by operating activities 398.4 233.8 Investing activities Capital expenditures (105.5) (100.6) Business acquisitions, net of cash acquired (1,426.1) (47.6) Settlement of foreign exchange derivatives 93.3 — Proceeds from divestiture 928.2 — Other investing activities 6.1 (2.0) Net cash used by investing activities (504.0) (150.2) Financing activities Debt offering proceeds 1,300.0 — Purchase of common shares for treasury (36.4) (4.2) Cash dividends paid (86.8) (77.7) Repayment of long-term debt (956.8) (18.5) Payments on withholding tax on share awards (4.3) (10.7) Debt financing costs (49.3) — Other financing activities — (3.5) Net cash provided (used) by financing activities 166.4 (114.6) Effect of exchange rate changes on cash (20.9) (17.3) Increase (decrease) in cash and cash equivalents 39.9 (48.3) Cash and cash equivalents at beginning of year 601.2 649.5 Cash and cash equivalents at end of year $ 641.1 $ 601.2 13 Attachment 6 Avient Corporation Business Segment Operations (Unaudited) (In millions) Operating income at the segment level does not include: special items as defined in Attachment 3; corporate general and administration costs that are not allocated to segments; intersegment sales and profit eliminations; share-based compensation costs; and certain other items that are not included in the measure of segment profit and loss that is reported to and reviewed by the chief operating decision maker.
Three Months Ended December 31, Year Ended December 31, 2022 2021 2022 2021 Sales: Color, Additives and Inks $ 490.8 $ 581.3 $ 2,355.0 $ 2,401.6 Specialty Engineered Materials 300.8 226.3 1,044.4 911.6 Corporate (1.2) (0.5) (2.5) 2.3 Sales $ 790.4 $ 807.1 $ 3,396.9 $ 3,315.5 Gross margin: Color, Additives and Inks $ 134.5 $ 164.5 $ 681.3 $ 727.5 Specialty Engineered Materials 82.4 58.3 283.7 250.9 Corporate (44.9) (6.2) (82.3) (34.6) Gross margin $ 172.0 $ 216.6 $ 882.7 $ 943.8 Selling and administrative expense: Color, Additives and Inks $ 90.2 $ 103.3 $ 380.3 $ 424.4 Specialty Engineered Materials 47.2 31.2 143.6 125.4 Corporate 34.2 31.9 115.5 114.3 Selling and administrative expense $ 171.6 $ 166.4 $ 639.4 $ 664.1 Operating income: Color, Additives and Inks $ 44.3 $ 61.2 $ 301.0 $ 303.1 Specialty Engineered Materials 35.2 27.1 140.1 125.5 Corporate (79.1) (38.1) (197.8) (148.9) Operating income $ 0.4 $ 50.2 $ 243.3 $ 279.7 14 Attachment 7 Avient Corporation Reconciliation of Non-GAAP Financial Measures (Unaudited) (In millions, except per share data) Senior management uses gross margin before special items and operating income before special items to assess performance and allocate resources because senior management believes that these measures are useful in understanding current profitability levels and how it may serve as a basis for future performance.
https://www.avient.com/sites/default/files/resources/Investor%2520Presentation%2520Mar19.pdf
Investor Day POLYONE I N V E S T O R P R E S E N T A T I O N M A R C H 2 0 1 9 FORWARD LOOKING STATEMENTS PolyOne Corporation 2 • • • • • • • • • • USE OF NON-GAAP MEASURES PolyOne Corporation 3 • • • V I S I O N PolyOne Corporation 4 To be the world’s premier provider of specialized polymer materials, services and solutions C O R E V A L U E S P E R S O N A L V A L U E S Honesty IntegrityRespect Operational Excellence Commercial Excellence Specialization Globalization Collaboration ExcellenceInnovation To be the world’s premier provider of specialized polymer materials, services and solutions S A F E T Y F I R S T PolyOne Corporation 5 Injuries per 100 Workers Spartech Acquisition 1.3 1.1 1.1 0.85 0.65 0.57 0.54 0.97 0.84 0.74 0.74 0.69 0.51 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 PolyOne Corporation 6 P O L Y O N E 2 0 1 8 R E V E N U E | $ 3 . 5 B I L L I O N Transportation 17% Industrial 15% Consumer 12% Packaging 11% Wire & Cable 10% Appliance 5% United States 57% Europe 16% Asia 10% Latin America 10% Canada 7% Distribution 35% Performance Products & Solutions 19% Specialty Engineered Materials 17% Color Additives & Inks 29% Segment End Market Geography Building & Construction 11% Electrical & Electronics 6% Healthcare 13% 2009 2010 2011 2012 2013 2014 2015 2016* 2017* 2018 $2.43 P R O O F O F P E R F O R M A N C E C O N S E C U T I V E Y E A R S PolyOne Corporation 7 9 $0.13 $0.68 $0.82 $1.00 $1.31 $1.80 $1.96 $2.06 $2.21 2006 2018 ROIC** 5.0% 14.1% Operating Income % of Sales Color, Additives & Inks 1.7% 15.1% Specialty Engineered Materials 1.1% 11.2% Performance Products & Solutions 4.3% 10.0% Distribution 2.6% 5.6% A D J U S T E D E P S E X P A N S I O N S U S T A I N A B L E P A T H T O D O U B L E - D I G I T E P S G R O W T H PolyOne Corporation 8 P E O P L E P R O D U C T S P L A N E T P E R F O R M A N C E Double digit annual EPS growth strategic acquisitions Innovate 600K-1M commercial resources 5-7% Double acquired margins Lean Six Sigma commercial excellence 531 710 130 164 504 663 2014 2018 R&D / Technical Marketing Sales PolyOne Corporation 9 Increased commercial headcount + 34% + 26% + 32% I N V E S T M E N T I N COMMERCIAL RESOURCES D R I V I N G G R O W T H Sustained revenue increases led by organic business $2.9 $2.9 $3.2 $3.5 2015 2016 2017 2018 Total + 9% Organic + 5% Revenue in billions of $ Total + 10% Organic + 7% Lead Specialists T H E E V O L V I N G C U S T O M E R R E L A T I O N S H I P PolyOne Corporation 10 Expanded Path Traditional Path Strategic Accounts/ Field Sales Business Development Customer Service Web and Social Media Inside Sales PolyOne Corporation 11 Investments in digital and dedicated inside sales to improve customer experience 110% increase in leads (from 6,000 to 12,700) driven by website, phone, and online chat EXPANDED PATH A DDI N G C U S T O M E R T O U C H P O I N T S 4 24 2014 2018 Inside sellers $11M $109M 2014 2018 Inside sales/digital revenue A L I G N I N G W I T H T R E N D S F O R G R O W T H T R A N S P O R T A T I O N P A C K A G I N G H E A L T H C A R E C O N S U M E R PolyOne Corporation 12 Facilitate alternative energy solutions Light- weighting Reduce packaging materials Improve recyclability Reduce spread of infection I N N O V A T I O N PolyOne Corporation 13 Customization 55% M&A 30% Innovation Pipeline 15% Innovation comes from Research & Development Spend Vitality Index 12% 35% 2006 2018 $20 $56 2006 2018 Transformational Adjacent Core 3 H O R I Z O N S O F D E V E L O P M E N T PolyOne Corporation 14 Market Technical I N N O V A T I O N I N N O V A T I O N P I P E L I N E PolyOne Corporation 15 PrototypeFrame Opportunity Scale-up & Test Market Build Business Case Commercial Launch (since 2017) Phase 1 Phase 2 Phase 3 Phase 4 Phase 5 6 11 4 4 3 2 28 0 5 10 7 2 5 5 Breakthrough Platform Derivative F L A M E R E T A R D A N T P O L Y M E R S A D V A N C E D C O M P O S I T E S B A R R I E R M A T E R I A L S C O L O R A N T T E C H N O L O G I E S T H E R M O P L A S T I C E L A S T O M E R S I N N O V A T I O N S P O T L I G H T : C O M P O S I T E S PolyOne Corporation 16 C O M P O S I T E S R E F R E S H E R PolyOne Corporation 17 Fiber Polymer Composite S T R A T E G I C I N V E S T M E N T H I S T O R Y Thermoplastic Composites Long Fiber Reinforced Thermoplastics Continuous Fiber Thermosets Long Fiber Reinforced Thermoplastics Continuous Fiber Thermosets 2012 2015 20162009 2011 2018 PolyOne Corporation 2019 18 C O M P O S I T E S I N T R A N S P O R T A T I O N PolyOne Corporation 19 W A T E R C R A F TR A I L H E A V Y T R U C K F I B E R - L I N E H I G H L I G H T S PolyOne Corporation 20 $100M • • • • • • • • • • • • • • • • • • • Customer Value Fiber-Line Fiber Processing Capabilities Polymer Formulation Capabilities P O L Y O N E A P P L I C A T I O N S I N F I B E R O P T I C C A B L E S PolyOne Corporation 21 • • • • • • • • • F I B E R O P T I C A L G R O W T H D R I V E R S PolyOne Corporation 22 5G Networks 10x 8x 5G vs. 4G PolyOne Corporation 23 Safety Technology Geography Service FinancialPeople 8-10% with ability to double I N V E S T - T O - G R O W M & A S T R A T E G Y PolyOne Corporation 24 Capture sourcing synergies Cross-sell & blend technology 8-10% operating margins I N V E S T - T O - G R O W M & A P L A Y B O O K Protect customers Retain employees Implement LSS to drive efficiency improvements Innovate with combined portfolio Safety First!
Adjusted EPS attributable to PolyOne common shareholders is calculated as follows: 2009* 2010* 2011* 2012* 2013* 2014* 2015* 2016 2017 2018 Net income from continuing operations attributable to PolyOne common shareholders $ 106.7 $ 152.5 $ 153.4 $ 53.3 $ 94.0 $ 78.0 $ 144.6 $ 166.4 $ 173.5 $ 161.1 Joint venture equity earnings, after tax (19.0) (14.7) (3.7) — — — — — — — Special items, before tax(1) (48.7) 24.2 (48.1) 55.1 46.3 164.2 87.6 23.8 32.9 59.5 Special items, tax adjustments(1) (27.2) (96.7) (24.7) (18.9) (13.7) (73.7) (58.7) (15.9) (24.8) (25.3) Adjusted net income from continuing operations attributable to PolyOne common shareholders $ 11.8 $ 65.3 $ 76.9 $ 89.5 $ 126.6 $ 168.5 $ 173.5 $ 174.3 $ 181.6 $ 195.3 Diluted shares 93.4 96.0 94.3 89.8 96.5 93.5 88.7 84.6 82.1 80.4 Adjusted EPS attributable to PolyOne common shareholders $ 0.13 $ 0.68 $ 0.82 $ 1.00 $ 1.31 $ 1.80 $ 1.96 $ 2.06 $ 2.21 $ 2.43 * Historical results are shown as presented in prior filings and have not been updated to reflect subsequent changes in accounting principle, discontinued operations or the related resegmentation. (1) Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; costs incurred directly in relation to acquisitions or divestitures, including adjustments related to contingent consideration; employee separation costs resulting from personnel reduction programs, plant realignment costs, executive separation agreements; asset impairments; mark-to-market adjustments associated with actuarial gains and losses on pension and other post-retirement benefit plans; environmental remediation costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, joint ventures and equity investments; gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non- recurring items; and the effect of changes in accounting principles or other such laws or provisions affecting reported results.
Tax adjustments include the net tax benefit/(expense) from one-time income tax items, the set-up or reversal of uncertain tax position reserves and deferred income tax valuation allowance adjustments.
https://www.avient.com/products/vinyl-formulations/vinyl-powder-coating-and-dip-molding/core-vbx-series-vinyl-powder-slush-formulations
Engineered Polymer Formulations
Custom specialty engineered thermoplastic formulations designed to meet your application requirements